![Greg Hurlbut](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Greg Hurlbut is the founder of Sionna Therapeutics, Inc. since 2019, holding the title of Senior Vice President-Discovery Research.
Former job includes Head-Protein Conformational Diseases at Genzyme Therapeutics Ltd. Education includes an undergraduate degree from the University of Massachusetts and a doctorate from Université Paris-Saclay.
Postes actifs de Greg Hurlbut
| Sociétés | Poste | Début |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | Fondateur | 01/08/2019 |
Anciens postes connus de Greg Hurlbut
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | - |
Formation de Greg Hurlbut
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Choisissez Zonebourse 
